Physician profile
John B Schenck
NPI 1942362793
$11,512.12
in general payments reported to CMS, 2019-2025
54 companies · $2,308 in 2025
The $2,308 reported for 2025 was more than what 79% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $1,621 · 2021: $912 · 2022: $1,197 · 2023: $1,617 · 2024: $2,392 · 2025: $2,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,316.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,783.91 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,096.25 | 2020-2025 | Freestyle Libre 3 |
| Insulet Corporation | $1,024.73 | 2019-2025 | Omnipod |
| Amgen INC. | $935.21 | 2019-2025 | Evenity, Tepezza, Repatha |
| Novo Nordisk INC | $779.55 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Sanofi-Aventis U.S. LLC | $687.83 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.33 | 2019-2025 | Jardiance |
| Tandem Diabetes Care, INC. | $435.08 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $397.15 | 2021-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $348.53 | 2019-2025 | Tymlos |
| Abbvie INC. | $287.44 | 2019-2024 | |
| Cequr Corporation | $279.79 | 2022-2025 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals LP | $234.13 | 2020-2025 | Lokelma |
| Horizon Therapeutics Plc | $228.87 | 2020-2022 | |
| Medtronic Minimed, INC. | $194.38 | 2019-2020 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $179.09 | 2025 | Yorvipath |
| Beta Bionics, INC. | $170.99 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Xeris Pharmaceuticals, INC. | $158.86 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $152.26 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $151.54 | 2021-2024 | Strensiq |
| Mannkind Corporation | $148.19 | 2019-2022 | |
| Ibsa Pharma INC. | $138.98 | 2019-2021 | |
| Valeritas, INC. | $136.26 | 2019 | |
| Ascensia Diabetes Care US INC. | $90.97 | 2023-2024 | |
| Recordati_rare_diseases_inc. | $84.11 | 2021-2025 | Signifor Lar, Isturisa |
| Sequel Med Tech, LLC | $82.44 | 2025 | Twiist |
| Medtronic, INC. | $74.90 | 2021-2025 | Intellis Adaptivestim, Minimed 780g |
| Globus Medical, INC. | $72.70 | 2025 | Senza |
| Halozyme INC | $61.04 | 2023 | |
| Amarin Pharma, INC. | $59.12 | 2019-2021 | |
| Zealand Pharma US, INC. | $57.76 | 2020 | |
| Neurocrine Biosciences, INC. | $44.18 | 2024-2025 | |
| Corcept Therapeutics | $41.65 | 2020-2021 | |
| Ultragenyx Pharmaceutical INC. | $40.60 | 2022 | |
| Averitas Pharma INC. | $34.52 | 2024 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.24 | 2019 | |
| Nevro Corp. | $29.91 | 2023 | Senza |
| Chiesi USA, INC. | $27.41 | 2025 | Mycapssa |
| Janssen Pharmaceuticals, INC | $25.44 | 2019-2020 | |
| Genentech USA, INC. | $24.22 | 2019 | |
| Companion Medical, INC. | $21.22 | 2020 | |
| Pfizer INC. | $21.15 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.24 | 2023 | |
| Becton, Dickinson and Company | $18.10 | 2020 | |
| Vistapharm, INC. | $16.27 | 2021 | |
| Lifescan, INC. | $15.59 | 2020 | |
| Antares Pharma, INC. | $15.09 | 2025 | Xyosted |
| Esperion Therapeutics, INC. | $15.03 | 2022 | |
| Sanofi Pasteur INC. | $14.87 | 2019 | |
| Shire North American Group INC | $14.56 | 2019 | |
| Intuity Medical INC | $13.42 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Takeda Pharmaceuticals U.S.A., INC. | $12.87 | 2021 | |
| Currax Pharmaceuticals LLC | $12.27 | 2020 | |
| Medtronic USA, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schenck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.